• 제목/요약/키워드: Stage of Cancer Survivorship

검색결과 6건 처리시간 0.021초

유방암 및 부인과 암 생존자의 삶의 질에 대한 생존단계별 비교 연구 (Comparison of Quality of Life on the Stage of Cancer Survivorship for Breast and Gynecological Cancer Survivors)

  • 임정원;한인영
    • 한국사회복지학
    • /
    • 제60권1호
    • /
    • pp.5-27
    • /
    • 2008
  • 본 연구는 유방암 및 부인과 암 생존자를 대상으로 암 생존 단계에 따른 삶의 질의 차이를 다각적인 측면에서 조사함으로써 그들의 삶의 질을 생존 단계별로 이해하는데 그 목적이 있다. 서울에 거주하는 110명의 유방암 및 부인과 암 생존자를 대상으로 세 개의 표준화된 삶의 질 척도를 사용하였고, 연구 분석을 위해 급성, 확장, 영속적 생존단계에 따라 크게 세 집단으로 구분하였다. 연구 결과는 암 생존자의 생존 기간이 길어지면서 신체적 측면에서의 삶의 질이 전반적으로 향상됨을 증명하였다. 하지만, 심리 사회적 기능과 관련된 영역에서는 유의미한 차이를 보여주지 못했다. 본 연구는 향후 암 생존자의 삶의 질을 향상시키기 위해, 생존 단계를 고려한 차별화된 전략 개발 및 다각적 측면에서의 사회사업적 접근을 시사한다.

  • PDF

부인암 환자의 생존단계별 건강증진행위, 외상 후 성장 및 삶의 질 비교 (The Comparison of Health Promotion Behavior, Post Traumatic Growth and Quality of Life according to Stages of Survivorship in Patients with Female Genital Neoplasm)

  • 이은실;박정숙
    • 성인간호학회지
    • /
    • 제25권3호
    • /
    • pp.312-321
    • /
    • 2013
  • Purpose: The purpose of this study was to compare health promotion behavior, post-traumatic growth and quality of life according to the stages of survivorship in patients with female genital neoplasm. Methods: Data were collected from August 1st, 2011 to September 31st 2011 from 142 gynecologic cancer patients who completed treatment or were treated at an out-patient clinic. The instrument were HPLP developed by Walker, Sechrist & Pender, PTGI developed by Tedeschi & Calhoun, and Korean C-QOL. Results: Health promotion behavior scores were significantly higher in the acute survival stage than the extended survival stage. Post-traumatic growth score was higher in the acute survival stage than the extended survival stage. The quality of life scores were higher in the lasting survival stage than the extended survival stage. Conclusion: Gynecological cancer patients in the extended survival stage reported low scores of health promotion behavior, post-traumatic growth and quality of life. Intervention needed to be developed to improve health promotion behavior, post-traumatic growth and quality of life for patients with female genital neoplasm in the extended survival stage.

Demographic and Survivorship Disparities in Non-muscle-invasive Bladder Cancer in the United States

  • Seo, Munseok;Langabeer, James R. II
    • Journal of Preventive Medicine and Public Health
    • /
    • 제51권5호
    • /
    • pp.242-247
    • /
    • 2018
  • Objectives: To examine survivorship disparities in demographic factors and risk status for non-muscle-invasive bladder cancer (NMIBC), which accounts for more than 75% of all urinary bladder cancers, but is highly curable with early identification and treatment. Methods: We used the US National Cancer Institute's Surveillance, Epidemiology, and End Results registries over a 19-year period (1988-2006) to examine survivorship disparities in age, sex, race/ethnicity, and marital status of patients and risk status classified by histologic grade, stage, size of tumor, and number of multiple primary tumors among NMIBC patients (n=29 326). We applied Kaplan-Meier (K-M) and Cox proportional hazard methods for survival analysis. Results: Among all urinary bladder cancer patients, the majority of NMIBCs were in male (74.1%), non-Latino white (86.7%), married (67.8%), and low-risk (37.6%) to intermediate-risk (44.8%) patients. The mean age was 68 years. Survivorship (in median life years) was highest for non-Latino white (5.4 years), married (5.4 years), and low-risk (5.7 years) patients (K-M analysis, p<0.001). We found significantly lower survivorship for elderly, male (female hazard ratio [HR], 0.96), Latino (HR, 1.20), and unmarried (married HR, 0.93) patients. Conclusions: Survivorship disparities were ubiquitous across age, sex, race/ethnicity, and marital status groups. Non-white, unmarried, and elderly patients had significantly shorter survivorship. The implications of these findings include the need for a heightened focus on health policy and more organized efforts to improve access to care in order to increase the chances of survival for all patients.

노인암 생존자의 삶의 질 관련요인 분석 : 2006-2016 고령화패널 조사 자료 활용 (Analysis of Factors Related to Quality of Life in Elderly Cancer Survivors : Using KLoSA 2006-2016)

  • 장혜경;박양춘;박소정
    • 대한예방한의학회지
    • /
    • 제23권2호
    • /
    • pp.11-23
    • /
    • 2019
  • Objectives : The purpose of this study was to explore factors related quality of life among cancer survivor in order to identify strategies for cancer survivors to go back to normal life and carry on stable and high quality life. Methods : This study used the $1^{st}$ to $6^{th}$ data of Korean Longitudinal Study of Aging(KLoSA). The sample of this study consisted of 118 cancer survivors, all of whom were diagnosed with cancer for more than 10 years later in 2016. Results : Regression analysis of major factors related to the quality of life of elderly cancer survivors showed that the results of 2006 and 2016 were different. In 2006, factors related to cancer were highly correlated with quality of life, but in 2016, it was associated with pain and depression. Conclusions : The results of this study confirm that the factors related to quality of life in cancer survivors change with survival period. Therefore, this study suggests comprehensive care strategies based on the stage of survivorship.

지역별 암모니터링 지표 개발을 위한 다차원적 암모니터링 지표 프레임워크: 암 환자 생애 연속성에 기반하여 (Multidimensional Cancer Monitoring Index Framework for Developing Regional Cancer Monitoring Index: Based on Cancer Continuum)

  • 권정아;김재현;장지은;김우림;전미선;정승연;;신재용
    • 보건행정학회지
    • /
    • 제30권4호
    • /
    • pp.433-437
    • /
    • 2020
  • Cancer is a disease which has the huge burden in worldwide, and cancer is the number one cause of death in Korea. At this point, the new framework for cancer monitoring index is required for regional cancer monitoring. Especially, cancer survivors are the important target which is rapidly increasing recently, also cancer survivor's quality of care should be considered in the cancer monitoring index framework. To develop the Multidimensional Cancer Monitoring Index considering cancer survivor's quality of care, we took into account cancer continuum which including prevention, detection, diagnosis, treatment, survivorship, assessment of quality of care and monitoring cancer patient, and end-of life care for stage. For target, components of health care delivery system such as patient, family, provider, payer, and policy maker are included. Also, Donabedian model which is a framework for examining health services and evaluating quality of health care such as structure, process, and outcome is applied to contents. This new cancer monitoring framework which includes multidimensional components could help to develop regional cancer monitoring index, and to make national cancer management and prevention policy in the future.

Metachronous second primary malignancy in head and neck cancer patients: is five years of follow-up sufficient?

  • Adeel, Mohammad;Siddiqi, Moghira Iqbal
    • Journal of the Korean Association of Oral and Maxillofacial Surgeons
    • /
    • 제44권5호
    • /
    • pp.220-224
    • /
    • 2018
  • Objectives: The aim of this study was to determine the incidence and characteristics of second primary malignancy (SPM) in patients with head and neck squamous cell carcinoma treated at a tertiary care hospital. Materials and Methods: We retrospectively reviewed the medical records of 221 patients who underwent surgery with or without adjuvant treatment for head and neck cancer from 2000 to 2002. Data of age, sex, risk factors, sites of primary and SPM, TNM stage of primary tumor, incidence of SPM, and survival were collected from medical charts. Results: Eighteen patients developed SPM during a median follow-up of 67 months, with an overall incidence of 8.14%. In addition, 77.7% of SPMs occurred in the oral cavity, followed by 11% in the lungs. The 5-year overall survival after the diagnosis of SPM in the head or neck was 70%, compared to 30% for SPM in other body regions. Conclusion: Considering a high incidence of SPM, i.e., 8.14%, in a mean follow-up period of 67 months suggests the need for long-term follow-up. Since treatment of SPM has shown an acceptable survival rate, early detection and curative therapy should be emphasized.